Logo image of CHAC

CHARDAN HEALTHCARE ACQUISITION (CHAC) Stock Price, Quote, News and Overview

NYSEARCA:CHAC - NYSE Arca -

10.55  -0.25 (-2.31%)

CHAC Quote, Performance and Key Statistics

CHARDAN HEALTHCARE ACQUISITION

NYSEARCA:CHAC (10/28/2019, 8:09:22 PM)

10.55

-0.25 (-2.31%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High11.9
52 Week Low9.55
Market Cap92.31M
Shares8.75M
FloatN/A
Yearly Dividend0
Dividend Yield0%
PE60.6
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


CHAC short term performance overview.The bars show the price performance of CHAC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8

CHAC long term performance overview.The bars show the price performance of CHAC in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of CHAC is 10.55 null. In the past month the price increased by 4.35%.

CHARDAN HEALTHCARE ACQUISITION / CHAC Daily stock chart

About CHAC

Company Profile

Chardan Healthcare Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. Chardan Healthcare Acquisition Corp is based in New York, United States.

Company Info

CHARDAN HEALTHCARE ACQUISITION

17 STATE STREET 21ST FLOOR SUITE 2100

NEW YORK NY 10004

CEO: Jonas Grossman

Phone: 646-465-9001

CHARDAN HEALTHCARE ACQUISITION / CHAC FAQ

What is the stock price of CHARDAN HEALTHCARE ACQUISITION today?

The current stock price of CHAC is 10.55 null. The price decreased by -2.31% in the last trading session.


What is the ticker symbol for CHARDAN HEALTHCARE ACQUISITION stock?

The exchange symbol of CHARDAN HEALTHCARE ACQUISITION is CHAC and it is listed on the NYSE Arca exchange.


On which exchange is CHAC stock listed?

CHAC stock is listed on the NYSE Arca exchange.


What is CHARDAN HEALTHCARE ACQUISITION worth?

CHARDAN HEALTHCARE ACQUISITION (CHAC) has a market capitalization of 92.31M null. This makes CHAC a Micro Cap stock.


What are the support and resistance levels for CHARDAN HEALTHCARE ACQUISITION (CHAC) stock?

CHARDAN HEALTHCARE ACQUISITION (CHAC) has a support level at 10.29 and a resistance level at 10.81. Check the full technical report for a detailed analysis of CHAC support and resistance levels.


Should I buy CHARDAN HEALTHCARE ACQUISITION (CHAC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CHARDAN HEALTHCARE ACQUISITION (CHAC) stock pay dividends?

CHAC does not pay a dividend.


What is the Price/Earnings (PE) ratio of CHARDAN HEALTHCARE ACQUISITION (CHAC)?

The PE ratio for CHARDAN HEALTHCARE ACQUISITION (CHAC) is 60.6. This is based on the reported non-GAAP earnings per share of 0.17 and the current share price of 10.55 null. Check the full fundamental report for a full analysis of the valuation metrics for CHAC.


CHAC Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to CHAC.


Chartmill TA Rating
Chartmill Setup Rating

CHAC Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to CHAC. CHAC has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CHAC Financial Highlights

Over the last trailing twelve months CHAC reported a non-GAAP Earnings per Share(EPS) of 0.1741.


Industry RankSector Rank
PM (TTM) N/A
ROA 0.49%
ROE 6.95%
Debt/Equity 0.1
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

CHAC Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 100% to CHAC. The Buy consensus is the average rating of analysts ratings from 1 analysts.


Ownership
Inst Owners15.14%
Ins Owners42.37%
Short Float %N/A
Short RatioN/A
Analysts
Analysts100
Price TargetN/A
EPS Next Y-530.79%
Revenue Next YearN/A